ZA200709745B - Compositions and methods for inhibiting gastric acid secretion - Google Patents
Compositions and methods for inhibiting gastric acid secretionInfo
- Publication number
- ZA200709745B ZA200709745B ZA200709745A ZA200709745A ZA200709745B ZA 200709745 B ZA200709745 B ZA 200709745B ZA 200709745 A ZA200709745 A ZA 200709745A ZA 200709745 A ZA200709745 A ZA 200709745A ZA 200709745 B ZA200709745 B ZA 200709745B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- methods
- gastric acid
- acid secretion
- inhibiting gastric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67966405P | 2005-05-11 | 2005-05-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200709745B true ZA200709745B (en) | 2008-11-26 |
Family
ID=37396225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200709745A ZA200709745B (en) | 2005-05-11 | 2007-11-13 | Compositions and methods for inhibiting gastric acid secretion |
Country Status (16)
Country | Link |
---|---|
US (2) | US7803817B2 (ko) |
EP (1) | EP1879566B1 (ko) |
JP (1) | JP5161071B2 (ko) |
KR (2) | KR101447909B1 (ko) |
CN (1) | CN101184482B (ko) |
AU (1) | AU2005331689B2 (ko) |
CA (1) | CA2607803C (ko) |
DK (1) | DK1879566T3 (ko) |
ES (1) | ES2482771T3 (ko) |
HK (1) | HK1120421A1 (ko) |
IL (1) | IL187236A (ko) |
PL (1) | PL1879566T3 (ko) |
RU (1) | RU2385154C2 (ko) |
TW (1) | TWI388316B (ko) |
WO (1) | WO2006120500A1 (ko) |
ZA (1) | ZA200709745B (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
JP5563735B2 (ja) | 2004-06-16 | 2014-07-30 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | Ppi多回剤形 |
US7981908B2 (en) * | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US7803817B2 (en) * | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
WO2009005379A1 (en) * | 2007-07-03 | 2009-01-08 | Danuta Kruszewska | New medical applications of alpha-ketoglutarate |
PL226695B1 (pl) * | 2006-07-03 | 2017-08-31 | Danuta Kruszewska | Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori |
WO2008012621A2 (en) | 2006-07-25 | 2008-01-31 | Vecta, Ltd. | Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi |
SE0602446L (sv) * | 2006-11-16 | 2008-05-17 | Entress Ab | Ny användning av kända farmakologiskt aktiva kemiska sammansättningar |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
CN104069088A (zh) * | 2007-10-12 | 2014-10-01 | 武田制药北美公司 | 与食物摄入无关的治疗胃肠病症的方法 |
AU2008343787B2 (en) * | 2007-12-28 | 2014-01-30 | Impax Laboratories, Llc | Controlled release formulations of levodopa and uses thereof |
ES2370790B2 (es) * | 2010-05-25 | 2012-10-18 | Universidade De Santiago De Compostela | Uso de oxalacetato en el tratamiento de isquemia. |
US8691275B2 (en) | 2011-01-28 | 2014-04-08 | Zx Pharma, Llc | Controlled-release melatonin compositions and related methods |
US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
CA2826889C (en) | 2011-02-11 | 2016-12-20 | Zx Pharma, Llc | Multiparticulate l-menthol formulations and related methods |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
ES2706152T3 (es) | 2013-04-23 | 2019-03-27 | Zx Pharma Llc | Composición entérica de múltiples partículas revestida con subrevestimiento proteico |
US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
WO2020131650A1 (en) | 2018-12-20 | 2020-06-25 | Colgate-Palmolive Company | Oral care composition comprising zinc and an amino acid for treating symptoms of a gastric disorder in the oral cavity |
CN114315750B (zh) * | 2020-09-29 | 2024-05-10 | 鲁南制药集团股份有限公司 | 一种莫沙必利-丁二酸共晶 |
Family Cites Families (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2343011A (en) | 1941-07-11 | 1944-02-29 | Huppert Oskar | Thio-protein plastic |
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
JPS59104326A (ja) | 1982-12-04 | 1984-06-16 | Toyo Jozo Co Ltd | マクロライド抗生物質の安定な経口用製剤および安定化法 |
SE8301182D0 (sv) | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
JPS60193917A (ja) | 1984-03-14 | 1985-10-02 | R P Shiila- Kk | 多重構造軟カプセル剤 |
IL75400A (en) | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPS6150978A (ja) | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
AU4640985A (en) | 1984-08-31 | 1986-03-06 | Nippon Chemiphar Co. Ltd. | Benzimidazole derivatives |
US4767627A (en) | 1985-05-29 | 1988-08-30 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
US5238686A (en) | 1986-03-27 | 1993-08-24 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
GB2189699A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
GB8621425D0 (en) | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
IL88507A (en) | 1987-12-03 | 1993-02-21 | Smithkline Beckman Intercredit | 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them |
SE8804629D0 (sv) | 1988-12-22 | 1988-12-22 | Ab Haessle | New therapeutically active compounds |
JP2656338B2 (ja) | 1989-01-31 | 1997-09-24 | 日東電工株式会社 | 口腔粘膜貼付製剤 |
CA2015981A1 (en) | 1989-05-10 | 1990-11-10 | Thomas H. Brown | Compounds |
US5048353A (en) | 1990-03-01 | 1991-09-17 | Beloit Corporation | Method and apparatus for roll profile measurement |
JPH03287103A (ja) | 1990-04-02 | 1991-12-17 | Seiko Epson Corp | カラーフィルターの形成法 |
RO110497B1 (ro) | 1990-06-20 | 1996-01-30 | Astra Ab | Derivati dialcoxipiridinil benzimidazol, procedeu pentru prepararea lor si intermediari pentru realizarea procedeului |
SE9002206D0 (sv) | 1990-06-20 | 1990-06-20 | Haessle Ab | New compounds |
EP0617958A4 (de) | 1992-07-06 | 1995-09-06 | Irina Alexeevna Komissarova | pharmazeutische Zusammensetzung zur Behandlung von Alkoholismus, zur Stimulierungvon Katabolismus und Magensekretion und zumSchutze gegen Strahlenbeschädigung und Cholera. |
US7795239B2 (en) | 1992-07-27 | 2010-09-14 | Mueller Medical International LLC | Saccharide compositions and method of use |
SE9301489D0 (sv) * | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
SE9301830D0 (sv) | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SE9302396D0 (sv) | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
DE69530989T2 (de) | 1994-08-13 | 2004-05-19 | Yuhan Corp. | Neue pyrimidinderivate und verfahren zu ihrer herstellung |
ES2094694B1 (es) | 1995-02-01 | 1997-12-16 | Esteve Quimica Sa | Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion. |
SE9500422D0 (sv) | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
US6132768A (en) | 1995-07-05 | 2000-10-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
SE512835C2 (sv) | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
US5677302A (en) | 1996-02-26 | 1997-10-14 | Apotex Inc. | Thiadiazole compounds useful as proton pump inhibitors |
US5972389A (en) * | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
US5800832A (en) | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
SE9702533D0 (sv) * | 1997-07-01 | 1997-07-01 | Astra Ab | New oral formulation |
US6296876B1 (en) | 1997-10-06 | 2001-10-02 | Isa Odidi | Pharmaceutical formulations for acid labile substances |
ATE260090T1 (de) * | 1997-12-08 | 2004-03-15 | Altana Pharma Ag | Neue suppositoriumsform mit säureempfindliche wirkstoffe |
IT1296980B1 (it) | 1997-12-17 | 1999-08-03 | Istituto Pirri S R L | Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple |
SE9704870D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
DE69916273T2 (de) | 1998-06-18 | 2005-05-19 | Vecta Ltd. | Verwendung von gastrin fragmenten oder sythetischen analogen von gastrin zur herstellung eines arzneimittels zur behandlung der helicobacter pylori assozierten störungen |
SE9902386D0 (sv) | 1999-06-22 | 1999-06-22 | Astra Ab | New formulation |
US6228400B1 (en) | 1999-09-28 | 2001-05-08 | Carlsbad Technology, Inc. | Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
US7365047B1 (en) | 1999-09-28 | 2008-04-29 | The Regents Of The University Of California | Use of pentagastrin to inhibit gastric acid secretion or as a diuretic |
US7429599B2 (en) | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
WO2002086504A2 (en) | 2001-04-24 | 2002-10-31 | Mcgill University | Individualization of therapy with gastroesophageal reflux disease agents |
US6298876B1 (en) * | 2001-05-02 | 2001-10-09 | Ozone Industries, Inc. | Quick disconnect coupling |
US20030235628A1 (en) | 2001-09-19 | 2003-12-25 | Rajneesh Taneja | Methods and pharmaceutical formulations for protecting pharmaceutical compounds from acidic environments |
US20030175360A1 (en) | 2002-02-22 | 2003-09-18 | Renzo Luzzatti | Symptomatic relief of gastrointestinal disorders |
US20030181488A1 (en) | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
NZ536267A (en) | 2002-04-10 | 2007-06-29 | Fred H Miller | Multi-phase, multi-compartment and multi-ingredient capsular system |
ES2377002T3 (es) | 2002-06-06 | 2012-03-21 | University Of Washington | Conjugados covalentes entre los endoperóxidos relacionados con la artemisinina y las proteínas transportadoras de hierro y procedimientos de utilización |
CA2500976A1 (en) | 2002-09-24 | 2004-04-08 | Gumlink A/S | Chewing gum comprising at least two different biodegradable polymers |
US20060135406A1 (en) * | 2002-10-14 | 2006-06-22 | Sabina Glozman | Compositions and methods for treating pathologies that necessitate suppression of gastric acid secretion |
IL152289A0 (en) * | 2002-10-14 | 2003-05-29 | Vectabiotics Ltd | Method and composition for inhibiting h.pylori infection in a mammalian tissue |
GB2396107A (en) | 2002-10-24 | 2004-06-16 | Micap Plc | Micro-organism microcapsules |
GB2394895A (en) | 2002-11-06 | 2004-05-12 | Cipla Ltd | Proton pump inhibitor composition in paste form |
JP2006518751A (ja) | 2003-02-20 | 2006-08-17 | サンタラス インコーポレイティッド | 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物 |
EP2112920B1 (en) * | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
CA2536906A1 (en) * | 2003-08-27 | 2005-03-10 | Vecta Ltd. | Compositions for treating pathologies that necessitate suppression of gastric acid secretion |
MXPA06002443A (es) | 2003-09-03 | 2006-08-31 | Agi Therapeutics Ltd | Formulaciones inhibidoras de la bomba de protones y metodos para preparar y utilizar tales formulaciones. |
US7211568B2 (en) | 2003-12-18 | 2007-05-01 | Kosan Biosciences Incorporated | 9-Desoxoerythromycin compounds as prokinetic agents |
WO2005065664A1 (en) | 2004-01-06 | 2005-07-21 | Panacea Biotec Ltd. | Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent |
US20050181052A1 (en) | 2004-02-17 | 2005-08-18 | Patel Satishkumar A. | Lansoprazole microtablets |
MXPA06011820A (es) | 2004-04-16 | 2006-12-15 | Santarus Inc | Combinacion de inhibidor de bomba de proton, agente regulador del ph y agente procinetico. |
JP2008520547A (ja) | 2004-10-04 | 2008-06-19 | キューエルティー ユーエスエー,インコーポレイテッド. | 眼部送達のためのポリマー送達処方 |
DE14172398T1 (de) | 2004-10-08 | 2015-01-08 | Forward Pharma A/S | Gesteuerte Freisetzung von pharmazeutischen Zusammensetzungen mit Fumarinsäureester |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
PL226695B1 (pl) | 2006-07-03 | 2017-08-31 | Danuta Kruszewska | Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori |
WO2008012621A2 (en) | 2006-07-25 | 2008-01-31 | Vecta, Ltd. | Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi |
US7918908B2 (en) | 2008-04-30 | 2011-04-05 | Venturedyne, Ltd. | Dust collector with equalized cleaning performance |
-
2005
- 2005-07-27 US US11/191,688 patent/US7803817B2/en not_active Expired - Fee Related
- 2005-07-28 KR KR1020127010158A patent/KR101447909B1/ko not_active IP Right Cessation
- 2005-07-28 PL PL05780180T patent/PL1879566T3/pl unknown
- 2005-07-28 RU RU2007140941/15A patent/RU2385154C2/ru not_active IP Right Cessation
- 2005-07-28 AU AU2005331689A patent/AU2005331689B2/en not_active Ceased
- 2005-07-28 WO PCT/IB2005/002223 patent/WO2006120500A1/en active Application Filing
- 2005-07-28 DK DK05780180.5T patent/DK1879566T3/da active
- 2005-07-28 KR KR1020077027114A patent/KR101421994B1/ko not_active IP Right Cessation
- 2005-07-28 CN CN2005800497263A patent/CN101184482B/zh not_active Expired - Fee Related
- 2005-07-28 ES ES05780180.5T patent/ES2482771T3/es active Active
- 2005-07-28 CA CA2607803A patent/CA2607803C/en active Active
- 2005-07-28 JP JP2008510651A patent/JP5161071B2/ja not_active Expired - Fee Related
- 2005-07-28 EP EP05780180.5A patent/EP1879566B1/en not_active Not-in-force
-
2006
- 2006-03-24 TW TW095110341A patent/TWI388316B/zh not_active IP Right Cessation
-
2007
- 2007-11-08 IL IL187236A patent/IL187236A/en not_active IP Right Cessation
- 2007-11-13 ZA ZA200709745A patent/ZA200709745B/xx unknown
-
2008
- 2008-11-07 HK HK08112280.6A patent/HK1120421A1/xx not_active IP Right Cessation
-
2010
- 2010-04-27 US US12/768,375 patent/US9278080B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HK1120421A1 (en) | 2009-04-03 |
RU2007140941A (ru) | 2009-06-20 |
EP1879566B1 (en) | 2014-03-12 |
PL1879566T3 (pl) | 2015-01-30 |
IL187236A (en) | 2016-07-31 |
CN101184482A (zh) | 2008-05-21 |
CA2607803A1 (en) | 2006-11-16 |
CA2607803C (en) | 2013-12-17 |
RU2385154C2 (ru) | 2010-03-27 |
IL187236A0 (en) | 2008-06-05 |
ES2482771T3 (es) | 2014-08-04 |
KR20080005566A (ko) | 2008-01-14 |
KR101421994B1 (ko) | 2014-07-22 |
DK1879566T3 (da) | 2014-06-10 |
KR101447909B1 (ko) | 2014-10-08 |
AU2005331689B2 (en) | 2011-05-19 |
EP1879566A4 (en) | 2009-04-15 |
EP1879566A1 (en) | 2008-01-23 |
JP5161071B2 (ja) | 2013-03-13 |
WO2006120500A1 (en) | 2006-11-16 |
US9278080B2 (en) | 2016-03-08 |
US20100247634A1 (en) | 2010-09-30 |
US7803817B2 (en) | 2010-09-28 |
AU2005331689A1 (en) | 2006-11-16 |
JP2009502740A (ja) | 2009-01-29 |
CN101184482B (zh) | 2012-02-01 |
US20060257467A1 (en) | 2006-11-16 |
KR20120051097A (ko) | 2012-05-21 |
TWI388316B (zh) | 2013-03-11 |
TW200714278A (en) | 2007-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200709745B (en) | Compositions and methods for inhibiting gastric acid secretion | |
EP2005957A4 (en) | ACID SECRETION INHIBITOR | |
IL195619A0 (en) | Compositions and methods for joininig non-conjoined iumens | |
SI2137210T1 (sl) | Nov postopek in sestavki | |
EP1865779A4 (en) | COMPOSITIONS AND METHODS FOR ENHANCING CACHEXIA | |
PL1940839T3 (pl) | Pirydopirymidynonowe inhibitory PI3Kalfa | |
IL197555A0 (en) | Phosphorescent compositions and methods for identification using the same | |
HK1137670A1 (en) | Compositions and methods for arthrodetic procedures | |
EP1960781A4 (en) | COMPOSITIONS AND METHODS FOR DETECTING PHOSPHOMONOESTERS | |
ZA200803381B (en) | Methods and compositions for improving gastrointestinal health | |
GB0522287D0 (en) | Method and compositions | |
EP2217250A4 (en) | IMMUNOREGULATORY COMPOUNDS AND RELATED COMPOSITIONS AND METHODS | |
PL376178A1 (en) | Gastric acid secretion inhibiting composition | |
EP2049122A4 (en) | METHOD AND COMPOSITIONS FOR INHIBITING THE ANGIOGENESIS | |
HK1191861A1 (zh) | 胃酸分泌的快速作用抑制劑 | |
EP1968565A4 (en) | COMPOSITIONS AND METHODS FOR INHIBITING ANGIOGENESIS | |
EP1996218A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | |
GB0617171D0 (en) | Novel compositions and methods | |
EP2088865A4 (en) | METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS | |
GB0605247D0 (en) | Compositions and methods for immunisation | |
GB0524927D0 (en) | Compositions and method | |
ZA200806434B (en) | Calcium-enrichment compositions and methods for production thereof | |
EP2296470A4 (en) | COMPOSITIONS AND METHODS FOR INHIBITING GASTRIC ACID SECRETION | |
ZA200709852B (en) | Spiro-benzimidazoles as inhibitors of gastric acid secretion | |
KR100496606B1 (en) | Composition for anti-cancer comprising poly- -glutamic acid |